John Horseman’s Top Picks From the Latest 13F

In its latest 13F, John Horseman‘s Horseman Capital Management has disclosed its holdings as held at the end of the fourth quarter of 2013. The total value of the fund’s equity portfolio is approximately $322.72 million.

Vipshop Holdings Ltd

We have picked Horseman Capital Management’s top five holdings in terms of value that the fund has held in its equity portfolio at the end of last year.

First on the list is Vipshop Holdings Ltd (ADR) (NYSE:VIPS), in which the fund owns 371,800 shares, with a reported value of $31.12 million. The holding decreased from 401,600 shares at the end of third quarter. The China based online discount retailer has a market cap of $5.67 billion.

The next is the global technology giant, Google Inc. (NASDAQ:GOOG). The fund upped its stake to 24,900 shares, from 22,900 shares held at the end of September. The value of the current holding has surged to $27.91 million from $20.06 million in the previous quarter.

On the third spot is Wells Fargo & Co (NYSE:WFC), in which the fund disclosed a $25.84 million stake, which amasses 569,200 shares. The holding increased marginally from 523,600 shares held at the end of the third quarter of 2013. Another fund who is bullish on the bank holding company is Warren Buffett’s Berkshire Hathaway, with the largest stake of 463.46 million shares in the company.

The next on the list is the global investment bank, Goldman Sachs Group Inc (NYSE:GS), another stock, in which John Horseman increased his position to 135,500 shares, from 124,600 shares. The value of the current holding surged to $24.02 million from $19.71 million at the end of the third quarter.

Coach Inc (NYSE:COH), is the fifth largest holding. Horseman Capital Management increased its stake to 417,000 shares, which is equivalent to $23.41 million at the end of last year. This compares to 387,000 shares, worth $21.10 million, held by the fund in the third quarter of 2013.


Recommended Reading:

Richard Blum’s Latest 13F Shows Strong Focus on Services

Broadfin Capital Initiates Stake in Eleven Biotherapeutics (EBIO) Following Its IPO

Hedge Fund News: Thomas Steyer, David Einhorn & Carl Icahn

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!